Evaluation of the Epithelial Barrier Function and Ileal Microbiome in an Established Necrotic Enteritis Challenge Model in Broiler Chickens

Introduction

Clostridium perfringens (CP) is a Gram-positive anaerobe, spore-forming pathogen with a short replication rate in thioglycolate medium, and the capacity to produce more than 16 different toxins/enzymes with diverse modes of action (1–3). In mammals, it has been demonstrated that CP alpha-toxin is a key virulence factor in the pathogenesis of gas gangrene, since the injection of the alpha-toxin or injection of a beneficial Bacillus subtilis expressing the alpha-toxin can induce gangrene and tissue necrosis (4, 5). Alpha-toxin targets the liposomes of the cell membrane, as it contains phospholipase C and sphingomyelinase, disrupting the most important defensive organelle of the cell (6). Alpha-toxin is also responsible for hemolysis, tissue necrosis, epithelial barrier dysfunction, and severe inflammation as it activates the arachidonic acid pathway, the nuclear factor kappa beta pathway (NF-κβ), and the release of proinflammatory cytokines such as interferon gamma (IFN)-γ and tumor necrosis factor alpha (TNF)-α (7, 8). These physiological responses to alpha-toxin can also lead to edema due to increased vascular permeability (9, 10).

In chickens, CP type A and C are recognized as the primary causative agent of necrotic enteritis (NE), a multi-factorial disease that has a significant economic impact on the poultry industry with annual losses of ~2 billion dollars (11). However, even though alpha-toxin has been extensively studied in the pathogenesis of the disease (12–14), its role as the main virulent factor is no longer an accepted dogma. Few other toxins (NetB, Tpel) are now considered to be more important than alpha toxin in NE pathogenesis (3, 15). In fact, CP NetB-toxin has been also reported to induce NE without the presence of alpha-toxin (16, 17). In chickens, NE is characterized by high mortality, rapid loss in performance, depression, and a severe necrosis of the intestinal mucosa (18, 19). CP is ubiquitous and is harbored in the intestinal tract of metazoans. Hence, any condition that changes the normal microbiota (dysbacteriosis), could favor CP overgrowth and cause their toxins to rise leading to severe epithelial damage and necrosis of the intestinal absorptive surface (20–22).

Recent investigations have shown significant changes in the microbiome of chickens affected by NE when compared with healthy control chickens (23, 24). In this multi-factorial disease, coccidial infections, in particular with Eimeria maxima (EM) are recognized as pre-requisites in the pathogenesis of NE (11, 12). Likewise, diets with a high content of non-starch polysaccharides (NSP), immunosuppression, and withdrawal of antibiotic growth promoters or anticoccidials have been reported as factors related to the increased incidence of NE in chickens (25). The use of probiotics have been shown to reduce the incidence and severity of NE (24, 26), and these studies suggest that probiotics improve intestinal gut barrier function. However, to this date, there are no consistent results to prove this hypothesis. In an attempt to develop a reliable NE chicken model, our laboratory integrated different predisposing factors for presentation of NE that included a neonatal Salmonella Typhimurium (ST) challenge, followed by EM and CP challenges (27). Hence, the objectives of the present study were to evaluate the effect of NE on intestinal permeability and intestinal microbiome changes in broiler chickens in a laboratory challenge model that could be used to evaluate future alternative feed additive candidates to control the presentation of this important enteric disease.

Materials and Methods

Animal Source and Diets

For the NE challenge study, a total of 80 day-of-hatch Cobb 500 male broiler chicks were obtained from a commercial hatchery (Siloam Springs, AR, USA). Chickens were neck-tagged and randomly located to one of eight floor pens (206 × 104 cm) with new pine shavings as litter in an environmentally controlled room. The temperature was maintained at 34°C for the first 5 days and was then gradually reduced until a temperature of 23°C was achieved at day 21 of age. Lighting was provided for 18 h/day. Broilers chicks were fed with mash corn-soybean based diets. Starter (0–7 days) and grower (8–25 days) diets were formulated to approximate the nutritional requirements for broiler chickens as recommended by the National Research Council (28), and adjusted to breeder's recommendations (29). Water and feed were provided ad libitum. No antibiotics or anticoccidials were added to the feed. In the present study, all animal handling procedures were in compliance with the University of Arkansas, Institutional Animal Care and Use Committee (IACUC, approved protocol: 15006).

Salmonella Typhimurium

A poultry isolate of ST selected for resistance to 25 μg/mL nalidixic acid (NA, Sigma, St. Louis, MO) and 20 μg/mL novobiocin (NO, Sigma, St. Louis, MO) was used during this study. An aliquot of ST was thawed and 100 μL of culture was inoculated into 10 mL of tryptic soy broth (TSB, Sigma, St. Louis, MO) and incubated at 37°C for 18 h. This was followed by three more passages at intervals of 8 h into fresh TSB to ensure that all bacteria were in log phase. Post-incubation, bacterial cells were washed three times in sterile saline (0.9%) by centrifugation at 1,864 × g, 4°C for 15 min. The approximate concentration of ST was quantified spectrophotometrically (Spectronic 20D+, Spectronic Instruments Thermo Scientific, Madison, WI) at 625 nm and diluted with sterile saline to reach a challenged concentration of ~10⁷ cfu/mL. Additionally, this concentration was also determined retrospectively, by serial dilution and plating on brilliant green agar (BGA, Sigma, St. Louis, MO) with NA (25 μg/mL) and NO (20 μg/mL) for determination of actual ST colony forming units.

Eimeria maxima

Oocysts of the previously described EM Guelph strain (EM-GS) were donated by Dr. John. R. Barta, University of Guelph, Canada. The EM-GS strain is a single oocyst-derived isolate that has been maintained at the Ontario Veterinary College since 1973 (30). EM-GS oocysts were propagated in vivo in chickens experimentally inoculated with 10–30 × 10⁴ sporulated oocysts (31). The methods for detecting and recovering oocysts from infected chickens, oocyst sporulation as well as preparation of infective doses, have been previously described (32). A preliminary dose titration study was performed, offset by 1 week, to determine the EM-GS challenge dose before starting the NE study. At 13 days of age, all broilers were weighed, divided into four groups (n = 15/group) and challenged with three different doses (25,000, 40,000, and 50,000) of sporulated oocysts per mL by oral gavage. A group of chicks was sham challenged with saline as a negative control. Five days post-challenge, body weight (BW) and body weight gain (BWG) were recorded. Based on the criterion that the challenge dose caused sub-clinical coccidiosis, consisting of a reduction on performance parameters without the presentation of clinical signs, the lowest dose providing 25,000 oocyst per mL that caused a 24 % reduction in BWG was chosen for the present NE challenge model study. Doses corresponding to 40,000 and 50,000 oocysts per mL reduced BWG in a 27 and 28% respectively, but results were not significantly different from the lowest EM-GS challenge dose (data not shown).

Clostridium perfringens

For CP challenge, a previously described strain used in a NE model was kindly donated and confirmed alpha-toxin positive using a multiplex PCR assay (27, 33). The primer pair used for detection of CP toxin gene cpa was: Forward sequence: 5′ TGCATGAGCTTCAATTAGGT 3′; Reverse sequence: 5′ TTAGTTTTGCAACCTGCTGT 3′. A frozen aliquot was amplified in TSB with sodium thioglycolate (Becton Dickinson, Sparks, MD). The broth culture was plated on phenyl ethyl alcohol agar (PEA) plates (Becton Dickinson, Sparks, MD) with 5% sheep blood (Remel, Lenexa, KS) to confirm purity. Aliquots were made with 25% sterile glycerol and stored at −80°C until further use. A single aliquot was individually amplified in TSB with sodium thioglycolate overnight for the NE challenge study and the challenge dose was confirmed by plating 10-fold dilutions on tryptic soy agar (TSA, Becton Dickinson, Sparks, MD) with sodium thioglycolate.

Experimental Design

In the NE challenge trial, 80 neonatal broiler chicks were randomly assigned to either a negative control non-challenged group (NC) or a positive control group (PC). Each experimental group had four replicates of 10 broilers. In the PC group, chickens were orally challenged with ST (1 × 10⁷ cfu/chick) at day 1, followed by EM-GS (2.5 × 10⁴ oocyst/chick) at day 18 and CP (1 × 10⁸ cfu/chick/day) at 23–24 days of age, according to a previously published experimental model (27) and the results of the E. maxima dose titration study described above. The NC group was sham challenged twice with saline and once with TSB with sodium thioglycolate to simulate handling and challenge conditions of the PC. Weekly, all broilers were individually weighed and BW, BWG and pen feed intake (FI) were noted at the end of each phase to calculate the feed conversion ratio (FCR) for starter (0–7 days), grower (8–25 days), and overall (0–25 days) experimental phases. Additionally, chickens were also weighed before EM-GS and CP challenge to evaluate the possible impact of each pathogen on performance. At 25 days of age, all the animals were euthanized by cervical dislocation. Chickens with similar BW where randomly selected to collect the different samples. Liver tissue was obtained for determination of aerobic and anaerobic bacterial translocation (BT) from 3 birds per pen (n = 12/group). In the case of the evaluation of gut permeability, blood samples were collected to measure serum fluorescein isothiocyanate-dextran levels (FITC-d) from 5 chickens per replicate (n = 20/group). Determination of ileal microbiome was performed based on 16S rRNA gene sequence analysis from 3 birds per pen (n = 12/group). CP lesion scores (n = 40/group) were evaluated according to Prescott et al. (34): 0 = no lesions; 1 = thin-walled and friable intestines; 2 = focal necrosis, gas production and ulceration; 3 = extensive necrosis, hemorrhagic and gas-filled intestines; and 4 = generalized necrosis typical of field cases, marked hemorrhage. Morbidity was evaluated as negative (bright and alert) or positive (reduce spontaneous activity, isolation or lethargy) according to Shojadoost et al. (35). Details about measurement techniques are described below.

Bacterial Translocation

Briefly, the right half of the liver was removed from each chicken, collected into sterile bags, weighed, homogenized, and 1:4 w/v dilutions were made with sterile 0.9% saline. Ten-fold dilutions of each sample were subsequently made in a sterile 96 well Bacti flat bottom plate, and the diluted samples were plated on TSA with and without sodium thioglycolate for evaluation of anaerobic and aerobic BT. Anaerobic samples were incubated at 37°C for 24 h using an anaerobic chamber (GasPak™, Becton Dickinson, Sparks, MD). Aerobic samples were incubated under aerobic condition using the same temperature and time parameters (37°C for 24 h). Bacterial translocation was expressed in colony forming units (Log₁₀ cfu/gram of tissue).

Determination of Serum FITC-d Levels

Serum levels of fluorescein isothiocyanate dextran (FITC-d), a measurement of enteric inflammation and mucosal permeability were determined after all chickens received a single oral gavage dose of FITC-d (8.32 mg/kg). Blood samples were collected from the femoral artery 1 h post FITC-d administration and allowed to clot under room temperature for 3 h. Samples were subsequently centrifuged (1,000 × g for 15 min) to separate serum from red blood cells. The serum samples were then diluted in phosphate buffer saline (1:5), and fluorescence was measured at 485 nm excitation and 528 nm emission (Synergy HT, multimode micro plate reader, Bio Tek Instruments, Inc., VT, USA). Levels of fluorescence in the samples were converted to respective FITC-d ng per mL of serum based on a standard curve (36).

Preparation of the 16S rRNA Gene Amplicon Library for MiSeq Sequencing

Ileal contents (200 mg) from each bird were collected for DNA isolation utilizing QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA). The concentration of extracted DNA was diluted to 10 ng μL⁻¹ for the preparation of a sequencing library targeting the V4 region of the 16S rRNA gene (37). Isolated DNA samples were amplified via a PCR using dual-index primers and normalized the amplicons with a SequalPrep™ Normalization kit (Life Technology, Carlsbad, CA) according to the manufacturers' recommendation. The library was constructed by combining 5 μL of each normalized aliquot sample for further assessment. Library concentration and product size were confirmed using a KAPA Library Quantification Kit (Kapa Biosystems, Woburn, MA) via quantitative PCR (qPCR, Eppendorf, Westbury, NY) and an Agilent 2100 Bioanalyzer system (Agilent, Santa Clara, CA), respectively. The 20 nM of pooled library aliquot and the 20 nM of PhiX control v3 were combined with 0.2 N fresh NaOH and HT1 buffer and mixed a second time with 5% of the PhiX control v3. The 600 μL of the mixture containing pooled library, PhiX control v3, NaOH and HT1 buffer was subsequently loaded onto a MiSeq v2 reagent cartridge to run sequencing.

Analysis of Microbiome Sequencing Data by QIIME Pipeline

Raw sequencing read files were processed using quantitative insights into microbial ecology (QIIME) pipeline version 1.9.1[available at http://qiime.sourceforge.net/; (38)] at Jetstream cloud computing platform (39). Demultiplexed reads were joined together using fastq-join (40) option of QIIME. Reads that were quality filtered using multiple_split_libraries_fastq.py option of QIIME were used for chimeric sequences identification using USEARCH version 6.1.544 (41). After removing chimeric sequences, the operational taxonomic unit (OTU) picking and taxonomy assignment were performed using pick_open_reference_otus.py command of QIIME with uclust method (41). Taxonomy was assigned based on green genes taxonomy and reference database version 13_8 (42). Sequences that belong to Chloroplast and mitochondria were removed from OTU table as they are not the part of microbial communities and possible contamination of Chloroplast was previously described (43). The OTU table was normalized using cumulative sum scaling (44) before summarization and statistical comparisons of any taxa and diversity analyses. Beta diversity was calculated using weighted UniFrac metric with even sampling depth of 7,000 reads and statistical comparisons were made using analysis of similarities (ANOSIM) method.

Statistical Analysis

All data were subjected to one-way ANOVA as a completely randomized design using the GLM procedure of SAS (45). For evaluation of growth performance parameters (BW, BWG, FI, and FCR), each of the replicate pens was considered as the experimental unit (n = 4/group), whereas data on BT (n = 12/group), serum FITC-d level (n = 20/group) and ileal microbiome population assessment (n = 12/group) were based on randomly selected broilers from all replicates of each group. Treatment means were partitioned using Duncan's multiple range test at P < 0.05 indicating statistical significance. Mortality and morbidity were compared using the chi-square test of independence to determine significance (P < 0.05). Taxonomic and alpha diversity data analyzed by QIIME was imported to Microsoft Excel and JMP^® Genomics 9 to determine significant differences using Wilcoxon test where level of significance was set at P < 0.05.

Results

Overall Performance

The results of the evaluation of BW, BWG, FI and FCR in broiler chickens in a NE challenge model are summarized in Table 1. After 7 days of the neonatal ST challenge, there was a significant difference in BWG of 19 g between experimental groups. During the overall experimental period a significant reduction in BW (1149 vs. 854 g) and BWG (1107 vs. 811 g) were observed in the PC compared with NC group. FI was significantly reduced in the challenged group at 7 days (142 vs. 123 g) and 25 days (1754 vs. 1576 g) of age, resulting in a significant increase in the FCR from day 14–25 (1.650 vs. 2.240) and the overall experimental period in the PC compared to the unchallenged NC group (1.586 vs. 1.949).

TABLE 1

Table 1. Evaluation of body weight (BW), body weight gain (BWG), feed intake (FI), and feed conversion ratio (FCR) in broiler chickens in a Necrotic enteritis challenge model^c.

Body Weight Gain After E. maxima and C. perfringens Challenge

Figure 1 shows the results of the change in BWG after challenge with E. maxima and C. perfringens in a NE model. Chickens in PC group were weighed and challenged at day 18 of age with EM-GS (2.5 × 10⁴ oocysts/mL), and 5 days post-inoculation were weighed again to calculate the BWG difference. A reduction of 25.0% was observed in BWG in the PC with respect to non-challenged chickens in NC group (Figure 1A). Therefore, showing similar results as those of the preliminary dose titration study with the lowest 25,000 oocysts dose, resulting in a BWG difference of 24% (data not shown). Additionally, when broilers were orally administered for two consecutive days with CP, the PC showed a lost in BWG of −6.4% in comparison to the NC (Figure 1B). Therefore, the impact of CP administration in BWG was evidently higher compared to the EM-GS challenge alone, confirming the presentation of a synergistic detrimental effect on intestinal health.

FIGURE 1

Figure 1. Change in body weight gain (BWG; g/broiler) after challenge with (A) Eimeria maxima and (B) Clostridium perfringens in a Necrotic enteritis model.

Intestinal Permeability and Lesion Scores

Table 2 shows the results of the evaluation of gut permeability in a NE model measuring BT to the liver and serum FITC-d levels. A significant increase in both, aerobic (2.25 vs. 3.76 Log₁₀ cfu/g) and anaerobic (0.61 vs. 2.28 Log₁₀ cfu/g) BT to the liver tissue were observed in the PC challenge chickens when compared with the NC non-challenged chickens. Similarly, a significant increase in FITC-d leakage from the intestinal lumen to the serum was detected in challenged chickens at a magnitude 13.5-fold higher compared with unchallenged chickens (15.05 vs. 203.23 ng/mL). In the case of NE lesion scores, the NC showed no lesions (0.0), while the average lesion score for PC was 1.97, presenting focal necrosis, gas production and ulcerations in the intestinal mucosa.

TABLE 2

Table 2. Evaluation of gut permeability and ileal lesion scores in a necrotic enteritis challenge model.

Morbidity and Mortality

The results of morbidity and mortality of broiler chickens in the NE model are summarized in Table 3. As expected, no mortality or clinical signs were observed in the non-challenge group. Nevertheless, at day 23 of age in the PC group, 12.5% of the chickens started to show reduced spontaneous activity (P < 0.05). At the second day of CP challenge, 100% of the chickens exhibited clinical signs that included either reduce activity, isolation or pronounced lethargy (P < 0.01). Interestingly, a significant increase in mortality was expected by 25 days of age, however, no mortality was recorded in any of the evaluated groups.

TABLE 3

Table 3. Morbidity and mortality progression of broiler chickens in Necrotic enteritis model.

Summary and Comparision of Significant Taxa at Different Levels

The results showing relative abundance of major phyla, families, and genera are summarized in Figure 2. In addition, differentially abundant phyla, families, and genera at P < 0.05 are listed in Table 4. Firmicutes were found as a predominant phylum in both groups (NC; 68.46%, PC; 66.58%) followed by Proteobacteria (NC; 16.60%, PC; 18.69%), Bacteroidetes (NC; 5.72%, PC; 6.38%), and Actinobacteria (NC; 5.18%, PC; 2.91%) as shown in Figure 2A. Although, Firmicutes and Actinobacteria were found higher in NC group while Proteobacteria and Bacteroidetes were higher in PC group, significant difference was observed only with Actinobacteria (P < 0.01). The relative abundance of major families (≥1% in total) found on both groups is summarized in Figure 2B. In total, Lactobacillaceae (10.70%), Enterobacteriaceae (10%), Lachnospiraceae (9.20%), Clostridiaceae (7.40%), Ruminococcaceae (6%), Bacillaceae (4.7%), Turicibacteraceae (3.30%), and Peptostreptococcaceae (3.2%) were some of the major predominant families. As shown in Table 4, Brevibacteriaceae, Clostridiaceae, Flavobacteriaceae, Hyphomicrobiaceae, Microbacteriaceae, Moraxellaceae, Peptostreptococcaceae, Phyllobacteriaceae, Sphingobacteriaceae, Staphylococcaeae, and Turicibacteriaceae were significantly higher in NC group as compared to PC group (P < 0.05). On the contrary, Christensenellaceae, Enterobacteriaceae, Eryipelotrichaceae, Lactobacillaceae, Leuconostocaceae, Prevotellaceae, and Ruminococcaceae were significantly higher in PC group as compared to NC group (P < 0.05). Similarly, the relative abundance of top 18 major genera found on both groups is summarized in Figure 2C. In total, Lactobacillus, (10.58%), Turicibacter (3.33%), Enterococcus (2.65%), Ruminococcus (2.78%), Clostridium (2.41%), Bacillus (2.25%), Coprococcus (1.37%), and Oscillospira (1.19%) were predominant genera. As shown in Table 4, Brevibacterium, Devosia, Epulopiscium, Ochrobactrum, SMB53, and Turicibacter were found significantly higher in NC group as compared to PC group (P < 0.05). On the contrary, Butyrivibrio, Dorea, Lactobacillus, Mogibacterium, Oscillospira, Prevotella, Proteus, PSB-M-3, cc_115 of family Erysipelotrichaceae, and Ruminococcus were found significantly higher in PC group as compared to NC group (P < 0.05). Although not significant, Clostridium was found higher in PC group (2.98 ± 0.71%) as compared to NC group (1.84 ± 0.36%). Likewise, Gallibacterium was also found numerically higher in PC (0.79 ± 0.37%) as compared to NC (0.59 ± 0.35%).

FIGURE 2

Figure 2. Relative abundance (%) of bacteria at (A) Phylum, (B) Family, and (C) Genus levels in the ileum of negative and positive control (with induced necrotic enteritis) groups. Minor bacteria genera including unassigned values were included as “others”.

TABLE 4

Table 4. Relative abundance of phylum, family, and genera differentially present in the ileal microbiomes between negative control vs. positive control with induced necrotic enteritis^a.

Diversity Analyses

There was no significant difference in alpha diversity calculated by all three metrics (chao1, PD_whole_tree, and Observed_otus available in QIIME) between NC and PC groups (data not shown). However, ANOSIM result (R = 0.76, P = 0.001) showed significant difference in beta diversity measured by weighted UniFrac metric between NC and PC groups as demonstrated in PCoA plot (Figure 3). In addition, samples in NC group were more clustered together as compared to PC group in PCoA plot, suggesting less sample wise variations existed in the microbial communities in NC group than PC group.

FIGURE 3

Figure 3. PCoA plot showing beta diversity between Negative and Positive control (with induced necrotic enteritis) as measured by weighted UniFrac metric. ANOSIM results (R = 0.76, P = 0.001) showed significant difference in community structure between groups.

Discussion

The decrease in the use of antibiotics in the poultry industry has created an opportunity for the presentation of multi-factorial diseases such as the devastating NE (46, 47). Factors that increase the presentation of this enteric disease include inappropriate management and nutritional practices or presentation of coccidiosis, leading to chronic stress and breakdown of the fragile gut microbiome. Therefore, triggering an unfavorable state of dysbacteriosis, characterized by alterations in pH, increased mucus secretion, reduced transit time and most importantly, shifting of the bacterial community (48, 49). This series of changes create ideal conditions for the rapid growth of CP, which synthesizes a collection of over 16 toxins and enzymes, most of them targeting the cell membrane of the enterocytes (1, 50). The principal CP toxins will disrupt the cell membrane by altering the cellular permeability and osmotic pressure (alpha, beta, and epsilon toxins), or by destroying the actin cytoskeleton (iota toxin) (3, 15). Interestingly, CP enterotoxin (CPE) has a different target and mode of action, as it binds the claudin family of the tight junction (TJ) proteins, causing obliteration of TJ thus increasing paracellular permeability across the enterocytes (2, 51, 52). Nevertheless, it is also crucial to mention that not all bacteria from the genus Clostridium are considered pathogenic. Interestingly, most of commensal Clostridia play decisive roles in the physiology, immunology, and even cognitive activities as some of the most important butyric acid producing bacteria of the GIT (53–57).

In the case of the current study, three different pathogens were used to successfully induce NE by disrupting the intestinal homeostasis state. The NE model included a ST challenge in neonatal broiler chickens followed by an EM oral-gavage at day 18 of age and 2 consecutive days of CP administration (27). In contrast to the high mortality and severe macroscopic lesions reported previously, the macroscopic lesions observed in PC chickens were mild, and no mortality was observed in any of the two experimental groups. However, positive control chickens were challenged with a low virulent strain of EM (Guelph strain) in contrast to the highly virulent EM (M6) used by Shivaramaiah et al. (27). Nevertheless, in the present experiment, PC challenge chickens showed a significant reduction in performance parameters; increased morbidity; and enhanced gut permeability, evidenced by liver aerobic and anaerobic BT as well as higher serum leakage of FITC-d. Alterations in gut permeability are linked with translocation of bacterial from the intestinal lumen to the portal circulation in several pathological conditions that induce leaky gut and systemic inflammation (58, 59). In the current study, PC chickens contained 13.5-fold more FITC-d in the serum when compared with NC non-challenged chickens. The relevance of this finding is that due to its large size (3–5 kDa), FITC-d does not leak into circulation under normal conditions. However, any impairment of TJ increases the permeability of FITC-d into the blood after oral administration (60–62).

The immunosuppressive effect of ST in neonatal chickens has been previously reported (63). Hence, early infection with ST in our current model has been a more reliable way to induce NE rather than using immunosuppressive viruses (18, 25). Furthermore, ST induces activation of the NF-κβ and alteration in TJ (64–66). Additionally, because the life cycle of Eimeria spp. involves intracellular (asexual), and extracellular (sexual) phases, a severe immune response mediated by NF-κβ activation results in the release of IFN-γ and TNF-α that contribute to the pathophysiology of coccidiosis in chickens (67, 68). Under these conditions, TNF-α increases gut permeability by downregulating TJ proteins (69–71). Furthermore, Eimeria infections have been also reported to induce dysbiosis. In the present study, EM challenge had a significant impact in BWG that was even more profound after the CP challenge. The increased gut permeability observed in PC group may be the result of a synergistic effect of all three pathogens involved in the NE model used in this study (ST, EM, and CP). Compromising the intestinal permeability, the largest and most important barrier against external environmental agents, the absorption of nutrients was also negatively affected, which impacted the BWG observed in the PC group as has been previously reported (72–74). Another predisposing factor to induce the presentation of NE is the utilization of cereal grains with a high content of NSP (75–77). However, in this NE study the diets provided to the animals were based on the most common feed ingredients used in the poultry industry around the world to simulate commercial conditions.

Additionally, the bacterial taxonomy results obtained in the present study are fascinating. At the phylum level, the NC group showed a higher abundance of Firmicutes and Actinobacteria as compared to PC group, however, a significant difference was observed only with Actinobacteria. Similar changes of the Actinobacteria population have been previously observed in chickens challenged with CP and coccidia in comparison to non-challenged birds (23). The most relevant observation in NC chickens regarding the Actinobacteria phylum was the significantly higher abundance of the family Brevibacteriaceae and the genus Brevibacterium as compared to PC chickens. Likewise, Turicibacter, a genus of Gram-positive bacteria that has been recognized as an important butyric acid producer was also found significantly higher in NC chickens (78, 79). The NC treatment also showed a significantly higher abundance of Peptostreptococcaceae, a family of Gram-positive bacteria in the class Clostridia that represents another important group of butyric acid-forming bacteria (80, 81).

In contrast, the PC group showed numerically higher relative abundance of Proteobacteria and Bacteroidetes compared to NC group. A similar increment in the population of Proteobacteria and Bacteroidetes has been reported before in severe cases of NE (24). The phylum Proteobacteria contain many opportunistic pathogens including bacteria from the genera Escherichia, Salmonella, Campylobacter, and Proteus. Therefore, an increase in Proteobacteria could be related to a probable presentation of gut dysbiosis (82). Among Proteobacteria, Enterobacteriaceae at the family level and Proteus at the genus level were significantly higher in PC group as compared to NC group. Proteus is a genus that contains opportunistic pathogens including P. mirabilis which has been associated with urinary tract, wound, and nosocomial infections in humans and has been considered an important zoonotic pathogen with a wider host range (83, 84). In addition, P. mirabilis has been isolated from chicken carcasses (85) and droppings (86), and has shown multiple drug resistance to antibiotics including tetracycline, nalidixic acid, gentamycin, and ampicillin trimethoprim-sulfamethoxazole (86).

The most notable genera among the phylum Bacteroidetes was Prevotella, a genus of Gram-negative bacteria which was found significantly higher in PC group compared to NC group. On the other hand, in agreement with previous findings, Dorea that belongs to a genus of Gram-positive bacteria of the phylum Firmicutes was significantly higher in PC group as compared to NC group (23). Similarly, Ruminococcus, a genus of Gram-positive bacteria associated with phylum Firmicutes and family Ruminococcaceae was significantly higher in PC group. This is in agreement with a previous NE challenged study which reported significantly higher abundance of Ruminococcus in the ileum of PC chickens (24). In addition, Ruminococcus was also found to be associated with enteritis in humans (87, 88). The association of Ruminococcus to enteritis in both humans and chickens may be due to its ability to utilize mucin glycans as an energy source for proliferation (89). Furthermore, a numerically higher proportion of the genus Gallibacterium was also observed in PC chickens as compared to NC chickens. This treatment also showed higher proportions of Clostridium (P > 0.05) and Lactobacillus (P < 0.0001). It is unclear why PC group had a higher relative abundance of Lactobacillus, however, it could be related to the astonishingly rapid recovery of morbid birds in the PC at day 25. Similar to our findings, Lactobacillus was also reported significantly higher in ceca of chickens in a different NE model that were challenged with C. perfringens, coccidia, and supplemented with fishmeal in the diet as compared to the non-challenged group (23). On the contrary, Lactobacillus was significantly higher in NC group compared to PC group in another NE challenged model study (24). On the other hand, the beta diversity analysis shows clear differences between NC and PC groups, suggesting a major shift in the gut microbiome in PC groups due to the challenges used to induce NE.

In summary, the results of the present study suggest that NE impairs the gut epithelial barrier function and induces microbiome alterations in broiler chickens in a laboratory challenge model. This additional information related to the pathogenesis and development of NE could be helpful to understand in a commercial scenario the mechanism of action of some alternative feed additives used as a replacement of antibiotic treatments to control or prevent the presentation of this important enteric disease. Studies to evaluate the dietary inclusion of a Bacillus subtilis direct-fed microbial (Bacillus-DFM) selected for production of multiple exogenous enzymes are currently in progress using the previously described NE disease model. This Bacillus-DFM has shown to reduce both viscosity and CP proliferation under an in vitro digestive system and could be one of many alternatives available to mitigate or prevent NE development without the inclusion of in-feed antibiotics (90, 91).

Ethics Statement

All animals handling procedures were in compliance with the Institutional Animal Care and Use Committee at the University of Arkansas (IACUC, approved protocol: 15006).

Author Contributions

JL, GT conceived and planned the study. JL, GT supervised all research. LB provide the Clostridium perfringens strain. KT, LG, BM, and MB collected data. JL, SP, GT, BA, YK, and BH analyzed and interpreted data. JL, BA, and XH-V prepared the tables and prepared the figures. JL, BA, YK, XH-V, SR, and GT wrote and/or revised the manuscript. All the authors approved the final version of the manuscript.

Funding

This research was supported by the Arkansas Bioscience Institute under the project: Development of an avian model for evaluation early enteric microbial colonization on the gastrointestinal tract and immune function.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1. McDonel JL. Clostridium perfringens toxins (type a, b, c, d, e). Pharmacol Ther. (1980) 10:617–55. doi: 10.1016/0163-7258(80)90031-5

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Labbe R, Huang T. Generation times and modeling of enterotoxin-positive and enterotoxin-negative strains of Clostridium perfringens in laboratory media and ground beef. J Food Protect. (1995) 58:1303–6. doi: 10.4315/0362-028X-58.12.1303

CrossRef Full Text | Google Scholar

3. Uzal FA, Freedman JC, Shrestha A, Theoret JR, Garcia J, Awad MM, et al. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. (2014) 9:361–77. doi: 10.2217/fmb.13.168

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Williamson E, Titball RA. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine (1993) 11:1253–8. doi: 10.1016/0264-410X(93)90051-X

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α -toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol. (1995) 15:191–202. doi: 10.1111/j.1365-2958.1995.tb02234.x

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. (2008) 9:112–24. doi: 10.1038/nrm2330

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Neish AS, Gweirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, et al. Prokaryotic regulation of epithelial responses by inhibition of IkB-α ubiquitination. Science (2000) 289:1560–3. doi: 10.1126/science.289.5484.1560

CrossRef Full Text | Google Scholar

8. Xavier RJ, Podolsky DK. How to get along-friendly microbes in a hostile world. Science (2000) 289:1483–4. doi: 10.1126/science.289.5484.1483

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Sakurai J, Nagahama M, Oda M. Clostridium perfringens alpha-toxin: characterization and mode of action. J Biochem. (2004) 136:569–74. doi: 10.1093/jb/mvh161

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Nagahama M, Umezaki M, Oda M, Kobayashi K, Tone S, Suda T, et al. Clostridium perfringens iota-toxin b induces rapid cell necrosis. InfectImmun. (2011) 79:4353–60. doi: 10.1128/IAI.05677-11

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Hofacre CL. Necrotic enteritis, currently a billion dollar disease: is there anything new on the horizon. In: Lyons TP, Jacques KA editors. Science and Technology in the Feed Industry: Proceedings of Alltech's 17th Annual Symposium. Nottingham: Nottingham University Press (2001). p. 79–86.

12. Schoepe H, Pache C, Neubauer A, Potschka H, Schlapp T, Wieler LH, et al. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases. Infect Immun. (2001) 69:7194–6. doi: 10.1128/IAI.69.11.7194-7196.2001

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Sheedy SA, Ingham AB, Rood JI, Moore RJ. Highly conserved alpha-toxin sequences of avian isolates of Clostridium perfringens. J Clin Microbiol. (2004) 42:1345–7. doi: 10.1128/JCM.42.3.1345-1347.2003

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Feng Y, Gong J, Yu H, Jin Y, Zhu J, Han Y. Identification of changes in the composition of ileal bacterial microbiota of broiler chickens infected with Clostridium perfringens. Vet Microbiol. (2010) 140:116–21. doi: 10.1016/j.vetmic.2009.07.001

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Stiles BG, Barth G, Barth H, Popoff MR. Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man? Toxins (2013) 5:2138–60. doi: 10.3390/toxins5112138

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Keyburn AL, Sheedy SA, Ford ME, Williamson MM, Awad M, Rood JL, et al. Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect Immun. (2006) 74:6496–500. doi: 10.1128/IAI.00806-06

CrossRef Full Text | Google Scholar

17. Keyburn AL, Boyce JD, Vaz P, Bannam TL, Ford ME, Parker D, et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. (2008) 4:e26. doi: 10.1371/journal.ppat.0040026

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Truscott R, Al-Sheikhly F. Reproduction and treatment of necrotic enteritis in broilers. Am J Vet Res. (1997) 38:857–61.

PubMed Abstract | Google Scholar

19. Timbermont L, Haesebrouck F, Ducatelle R, Van Immerseel F. Necrotic enteritis in broilers: an updated review on the pathogenesis. Avian Pathol. (2011) 40:341–7. doi: 10.1080/03079457.2011.590967

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern Med Rev. (2004) 9:180–97.

PubMed Abstract | Google Scholar

21. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol. (2010) 12:5–9. doi: 10.1038/ni0111-5

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Rigottier-Gois L. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J. (2013) 7:1256–61. doi: 10.1038/ismej.2013.80

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Lin Y, Xu S, Zeng D, Ni X, Zhou M, Zeng Y, et al. Disruption in the cecal microbiota of chickens challenged with Clostridium perfringens and other factors was alleviated by Bacillus licheniformis supplementation. PLoS ONE (2017) 12:e0182426. doi: 10.1371/journal.pone.0182426

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Xu S, Lin Y, Zeng D, Zhou M, Zeng Y, Wang H, et al. Bacillus licheniformis normalize the ileum microbiota of chickens infected with necrotic enteritis. Sci Rep. (2018) 8:1744. doi: 10.1038/s41598-018-20059-z

PubMed Abstract | CrossRef Full Text | Google Scholar

25. McReynolds J, Byrd JA, Anderson RC, Moore RW, Edrington KJ, Genovese TL, et al. Evaluation of immunosuppressants and dietary mechanisms in an experimental disease model for necrotic enteritis. Poult Sci. (2004) 83:1948–52. doi: 10.1093/ps/83.12.1948

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Layton SL, Hernandez-Velasco X, Shivaramaiah C, Xavier J, Menconi A, Latorre JD, et al. The effect of a Lactobacillus-based probiotic for the control of necrotic enteritis in broilers. FNS (2013) 4:1–7. doi: 10.4236/fns.2013.411A001

CrossRef Full Text | Google Scholar

27. Shivaramaiah S, Wolfenden RE, Barta JR, Morgan MJ, Wolfenden AD, Hargis BM, et al. The role of an early Salmonella Typhimurium infection as a predisposing factor for necrotic enteritis in a laboratory challenge model. Avian Dis. (2011) 55:319–23. doi: 10.1637/9604-112910-ResNote.1

PubMed Abstract | CrossRef Full Text | Google Scholar

28. National Research Council. Nutrient Requirements of Poultry, 9th Edn. Washington, DC: National Academy Press (1994).

29. Cobb-Vantress Inc. Broiler Performance and Nutrition Supplement Cobb 500. Cobb-Vantress Inc. (2015). Available online at: https://cobb-guides.s3.amazonaws.com/a71b8bc0-bbd4-11e6-bd5d-55bb08833e29.pdf

30. Martin AG, Danforth HD, Barta JR, Fernando MA. Analysis of immunological cross-protection and sensitivities to anticoccidial drugs among five geographical and temporal strains of Eimeria maxima. Int J Parasitol. (1997) 27:527–33. doi: 10.1016/S0020-7519(97)00027-1

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Basak S, Lee S, Barta J, Fernando M. Differential display analysis of gene expression in two immunologically distinct strains of Eimeria maxima. Parasitol Res. (2006) 99:28–36. doi: 10.1007/s00436-005-0087-6

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Long PL, Joyner LP, Millard BJ, Norton CC. A guide to laboratory techniques used in the study and diagnosis of avian coccidiosis. Folia Vet Lat. (1976) 6:201–17.

PubMed Abstract | Google Scholar

33. Heikinheimo A, Korkeala H. Multiplex PCR assay for toxinotyping Clostridium perfringens isolates obtained from Finnish broiler chickens. Lett Appl Microbiol. (2005) 40:407–11. doi: 10.1111/j.1472-765X.2005.01702.x

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Prescott JF, Sivendra R, Barnum DA. The use of bacitracin in the prevention and treatment of experimentally-induced necrotic enteritis in the chicken. Can Vet J. (1978) 19:181–3.

PubMed Abstract | Google Scholar

35. Shojadoost B, Vince AR, Prescott JF. The successful experimental induction of necrotic enteritis in chickens by Clostridium perfringens: a critical review. Vet Res. (2012) 43:74. doi: 10.1186/1297-9716-43-74

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Baxter MFA, Merino-Guzman R, Latorre JD, Mahaffey BD, Yang Y, Teague K, et al. Optimizing fluorescein isothiocyanate dextran measurement as a biomarker in a 24-h feed restriction model to induce gut permeability in broiler chickens. Front Vet Sci. (2017) 4:56. doi: 10.3389/fvets.2017.00056

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. (2013) 79:5112–20. doi: 10.1128/AEM.01043-13

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods (2010) 7:335–6. doi: 10.1038/nmeth.f.303

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Stewart CA, Cockerill TM, Foster I, Hancock D, Merchant N, Skidmore E, et al. Jetstream: a self-provisioned, scalable science and engineering cloud environment. In: Proceedings of the 2015 XSEDE Conference: Scientific Advancements Enabled by Enhanced Cyberinfrastructure. Peterson GD, editor. St. Louis, MO: ACM New York (2015). p. 1–8.

Google Scholar

40. Aronesty E. Data From: Command-Line Tools for Processing Biological Sequencing data. Durham, NC: Expression Analysis (2011). Available online at: http://code.google.com/p/ea-utils

41. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (2010) 26:2460–1. doi: 10.1093/bioinformatics/btq461

PubMed Abstract | CrossRef Full Text | Google Scholar

42. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. (2006) 72:5069–72. doi: 10.1128/AEM.03006-05

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Hanshew AS, Mason CJ, Raffa KF, Currie CR. Minimization of chloroplast contamination in 16S rRNA gene pyrosequencing of insect herbivore bacterial communities. J Microbiol Meth. (2013) 95:149–55. doi: 10.1016/j.mimet.2013.08.007

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Paulson JN, Stine OC, Bravo HC, Pop M. Differential abundance analysis for microbial marker-gene surveys. Nat Meth. (2013) 10:1200–2. doi: 10.1038/nmeth.2658

PubMed Abstract | CrossRef Full Text | Google Scholar

45. SAS Institute Inc. SAS/Share: 9.4 User's Guide, 2nd Edn. Cary, NC: SAS^® Documentation (2002).

46. McDevitt RM, Brooker JD, Acamovic T, Sparks NHC. Necrotic enteritis: a continuing challenge for the poultry industry. Worlds Poult Sci J. (2006) 62:221–47. doi: 10.1079/WPS200593

CrossRef Full Text | Google Scholar

47. Zuidhof MJ, Schneider BL, Carney VL, Korver DR, Robinson FE. Growth, efficiency, and yield of commercial broilers from 1957, 1978 and 2005. Poult Sci. (2014) 93:2970–82. doi: 10.3382/ps.2014-04291

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Teirlynck E, Gussem MDE, Dewulf J, Haesebrouck F, Ducatelle R, Van Immerseel F. Morphometric evaluation of “dysbacteriosis” in broilers. Avian Pathol. (2011) 40:139–44. doi: 10.1080/03079457.2010.543414

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Chen J, Tellez G, Richards JD, Escobar J. Identification of potential biomarkers for gut barrier failure in broiler chickens. Front Vet Sci. (2015) 2:14. doi: 10.3389/fvets.2015.00014

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Moore RJ. Necrotic enteritis predisposing factors in broiler chickens. Avian Pathol. (2016) 45:275–81. doi: 10.1080/03079457.2016.1150587

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Nava P, Vidal JE. The CpAL system regulates changes of the trans-epithelial resistance of human enterocytes during Clostridium perfringens type C infection. Anaerobe (2016) 39:143–9. doi: 10.1016/j.anaerobe.2016.04.002

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Eichner M, Protze J, Piontek A, Krause G, Piontek J. Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin. Pflügers Arch. (2017) 469:77–90. doi: 10.1007/s00424-016-1902-x

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Tellez G, Higgins S, Donoghue A, Hargis B. Digestive physiology and the role of microorganisms. J Appl Poult Res. (2006) 15:136–44. doi: 10.1093/japr/15.1.136

CrossRef Full Text | Google Scholar

54. Tellez G. Prokaryotes versus eukaryotes: who is hosting whom? Front Vet Sci. (2014) 1:3. doi: 10.3389/fvets.2014.00003

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog. (2013) 5:23. doi: 10.1186/1757-4749-5-23

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Liu X, Cao S, Zhang X. Modulation of gut microbiota-brain axis by probiotics, prebiotics, and diet. J Agric Food Chem. (2015) 63:7885–95. doi: 10.1021/acs.jafc.5b02404

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Zhong Y, Nyman M, Fåk F. Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Mol Nutr Food Res. (2015) 59:2066–76. doi: 10.1002/mnfr.201500187

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Ilan Y. Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. World J. Gastroenterol. (2012) 18:2609–18. doi: 10.3748/wjg.v18.i21.2609

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol. (2012) 590:447–58. doi: 10.1113/jphysiol.2011.219691

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, Sitaraman SV, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS ONE (2009) 4:e6073. doi: 10.1371/journal.pone.0006073

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Vicuña EA, Kuttappan VA, Tellez G, Hernández-Velasco X, Galarza-Seeber R, Latorre JD, et al. Dose titration of FITC-D for optimal measurement of enteric inflammation in broiler chicks. Poult Sci. (2015) 94:1353–9. doi: 10.3382/ps/pev111

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Kuttappan VA, Vicuña EA, Latorre JD, Wolfenden AD, Tellez G, Hargis BM, et al. Evaluation of gastrointestinal leakage in multiple enteric inflammation models in chickens. Front Vet Sci. (2015) 2:66. doi: 10.3389/fvets.2015.00066

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Hassan JO, Curtiss R. Virulent Salmonella Typhimurium-induced lymphocyte depletion and immunosuppression in chickens. Infect Immun. (1994) 62:2027–36.

PubMed Abstract | Google Scholar

64. Van Immerseel F, De Buck J, De Smet I, Mast J, Haesebrouck F, Ducatelle R. Dynamics of immune cell infiltration in the caecal lamina propria of chickens after neonatal infection with a Salmonella Enteritidis strain. Dev Comp Immunol. (2002) 26:355–64. doi: 10.1016/S0145-305X(01)00084-2

PubMed Abstract | CrossRef Full Text | Google Scholar

65. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. (2006) 7:688–93. doi: 10.1038/sj.embor.7400731

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Moreira CG, Weinshenker D, Sperandio V. QseC mediates Salmonella enterica serovar Typhimurium virulence in vitro and in vivo. Infect Immun. (2010) 78:914–26. doi: 10.1128/IAI.01038-09

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Rose ME, Long P, Bradley J. Immune responses to infections with coccidia in chickens: gut hypersensitivity. Parasitology (1975) 71:357–68. doi: 10.1017/S0031182000047132

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Rev Vaccines. (2006) 5:143–63. doi: 10.1586/14760584.5.1.143

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Edelblum KL, Turner JR. The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol. (2009) 9:715–20. doi: 10.1016/j.coph.2009.06.022

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Aveleira CA, Lin CM, Abcouwer SF, Ambrósio AF, Antonetti DA. TNF-α signals through PKCξ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes (2010) 59:2872–82. doi: 10.2337/db09-1606

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Xu F, Zhang C, Graves DT. Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. Biomed Res Int. (2013) 2013:754802. doi: 10.1155/2013/754802

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Salminen S, Isolauri E. Intestinal colonization, microbiota, and probiotics. J Pediatr. (2006) 149:S115–20. doi: 10.1016/j.jpeds.2006.06.062

CrossRef Full Text | Google Scholar

73. Salzman NH. Microbiota-immune system interaction: an uneasy alliance. Curr Opin Microbiol. (2011) 14:99–105. doi: 10.1016/j.mib.2010.09.018

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Elson CO, Cong Y. Host-microbiota interactions in inflammatory bowel disease. Gut Microbes (2012) 3:332–44. doi: 10.4161/gmic.20228

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Choct M, Hughes RJ, Trimble RP, Angkanaporn K, Annison G. Non-starch polysaccharide-degrading enzymes increase the performance of broiler chickens fed wheat of low apparent metabolizable energy. J Nutr. (1995) 125:485–92.

PubMed Abstract | Google Scholar

76. Annett CB, Viste JR, Chirino-Trejo M, Classen HL, Middleton DM, Simko E. Necrotic enteritis: effect of barley, wheat and corn diets on proliferation of Clostridium perfringens type A. Avian Pathol. (2002) 31:598–601. doi: 10.1080/0307945021000024544

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Tellez G, Latorre JD, Kuttappan VA, Kogut MH, Wolfenden A, Hernández-Velasco X, et al. Utilization of rye as energy source affects bacterial translocation, intestinal viscosity, microbiota composition, and bone mineralization in broiler chickens. Front Genet. (2014) 5:339. doi: 10.3389/fgene.2014.00339

PubMed Abstract | CrossRef Full Text | Google Scholar

78. Zhong Y, Teixeira C, Marungruang N, Sae-Lim W, Tareke E, Anderson R, et al. Barley malt increases hindgut and portal butyric acid, modulates gene expression of gut tight junction proteins and Toll-like receptors in rats fed high-fat diets, but high advanced glycation end-products partially attenuate the effects. Food Funct. (2015) 6:3165–76. doi: 10.1039/c5fo00150a

PubMed Abstract | CrossRef Full Text | Google Scholar

79. Luo Y, Peng H, Wright A, Bai S, Ding X, Zeng Q, et al. Broilers fed dietary vitamins harbor higher diversity of cecal bacteria and higher ratio of Clostridium, Faecalibacterium, and Lactobacillus than broilers with no dietary vitamins revealed by 16S rRNA gene clone libraries. Poult Sci. (2013) 92:2358–66. doi: 10.3382/ps.2012-02935

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Hang I, Rinttila T, Zentek J, Kettunen A, Alaja S, Apajalahti J, et al. Effect of high contents of dietary animal-derived protein or carbohydrates on canine faecal microbiota. BMC Vet Res. (2012) 8:90. doi: 10.1186/1746-6148-8-90

PubMed Abstract | CrossRef Full Text | Google Scholar

81. Geirnaert A, Wang J, Tinck M, Steyaert A, Van den Abbeele P, Eeckhaut V, et al. Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model. FEMS Microbiol Ecol. (2015) 91:fiv054. doi: 10.1093/femsec/fiv054

PubMed Abstract | CrossRef Full Text | Google Scholar

82. Shin N, Whon TW, Bae J. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. (2015) 33:496–503. doi: 10.1016/j.tibtech.2015.06.011

PubMed Abstract | CrossRef Full Text | Google Scholar

83. Aragon LM, Mirelis B, Miro E, Mata C, Gomez L, Rivera A, et al. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases. J Antimicrob Chemother. (2008) 61:1029–32. doi: 10.1093/jac/dkn056

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. Complicated catheterassociated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. (2008) 21:26–59. doi: 10.1128/CMR.00019-07

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Wong MH, Wan HY, Chen S. Characterization of multidrug-resistant Proteus mirabilis isolated from chicken carcasses. Foodborne Pathog Dis. (2013) 10:177–81. doi: 10.1089/fpd.2012.1303

PubMed Abstract | CrossRef Full Text | Google Scholar

86. Nahar A, Siddiquee M, Nahar S, Anwar KS, Ali SI, Islam S. Multidrug resistant-Proteus mirabilis isolated from chicken droppings in commercial poultry farms: bio-security concern and emerging public health threat in Bangladesh. J Biosafety Health Edu. (2014) 2:2. doi: 10.4172/2332-0893.1000120

CrossRef Full Text | Google Scholar

87. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 139:1844–54. doi: 10.1053/j.gastro.2010.08.049

PubMed Abstract | CrossRef Full Text | Google Scholar

88. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut (2011) 60:631–7. doi: 10.1136/gut.2010.223263

PubMed Abstract | CrossRef Full Text

89. Crost EH, Tailford LE, Le Gall G, Fons M, Henrissat B, Juge N, et al. Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS ONE (2013) 8:e76341. doi: 10.1371/journal.pone.0076341

PubMed Abstract | CrossRef Full Text | Google Scholar

90. Latorre JD, Hernández-Velasco X, Kuttappan VA, Wolfenden RE, Vicente JL, Wolfenden AD, et al. Selection of Bacillus spp. for cellulase and xylanase production as direct-fed microbials to reduce digesta viscosity and Clostridium perfringens proliferation using an in vitro digestive model in different poultry diets. Front Vet Sci. (2015) 2:25. doi: 10.3389/fvets.2015.00025

PubMed Abstract | CrossRef Full Text | Google Scholar

91. Latorre JD, Hernandez-Velasco X, Wolfenden RE, Vicente JL, Wolfenden AD, Menconi A, et al. Evaluation and selection of Bacillus species based on enzyme production, antimicrobial activity, and biofilm synthesis as direct-fed microbial candidates for poultry. Front Vet Sci. (2016) 3:95. doi: 10.3389/fvets.2016.00095

PubMed Abstract | CrossRef Full Text | Google Scholar